Fig. 1From: Combination therapy with c-met inhibitor and TRAIL enhances apoptosis in dedifferentiated liposarcoma patient-derived cellsEfficacy of treatment with rhTRAIL in sarcoma cell lines. Cell viability of ADMSCs (a), MFH-ino (b), SW872 (c), and HT1080 (d) after 48 h of incubation with serial dilutions of rhTRAIL protein (0–10 ng/ml)Back to article page